Welcome to Biomaterials, Inflammation, and Tissue Engineering (BITE) Lab
We are a new research group at the F. Joseph Halcomb III, M.D. Department of Biomedical Engineering. We are interested in understanding the roles of the immune system in neotissue formation and applying this knowledge to the development of immunomodulatory biomaterials and immunotherapies for musculoskeletal and vascular regeneration. To this end, we study the role of macrophages in heterotrophic ossification (HO) and in various inflammatory conditions to elucidate their regenerative potential. We also develop microengineered biomaterial systems and immunomodulatory strategies to make cellular and molecular therapies useful in treating disease and trauma. Our research span both basic and translational research areas.
Our team will also be collaborating with faculties at the medical school in understanding the role of inflammation in cardiovascular diseases and cancer and in developing suitable therapies.
We are looking for energetic and passionate graduate and undergraduate students with chemical engineering, material science, mechanical engineering or biology background to join the team. Please directly email Dr. Ramkumar Annamalai for more information (more info).
We are grateful for funding from the College of Engineering and the Biomedical Engineering at the University of Kentucky.
BITE Lab welcomes three new graduate students Parto Babania, Harshini Suresh, and Matthew Patrick. Congrats on your acceptance to the BME graduate program.Dec 10, 2019
Eunjae's paper on 'Bioresponsive microspheres for on‐demand delivery of anti‐inflammatory cytokines for articular cartilage repair' published on JBMR Part-A.Jun 06, 2019
Dr. Annamalai will be presenting our work on 'Macrophage-mediated Release of BMP2 from Bioresponsive Microspheres for Vascularize bone Regeneration' in the upcoming BMES Conference at Philadelphia.May 05, 2019
Check out our recently published work on transport analysis of engineered liver tissue.May 02, 2019
Our work on 'Injectable microtissues containing MSC conformally fill and repair critical-size defects' just got accepted in Biomaterials journal. This is a promising cell therapy for nonunion fractures.